Synthesis and preclinical characterization of [64Cu]NODAGA-MAL-exendin-4 with a Nε-maleoyl-l-lysyl-glycine linkage-Reference-Cited by-同舟云学术

Synthesis and preclinical characterization of [64Cu]NODAGA-MAL-exendin-4 with a Nε-maleoyl-l-lysyl-glycine linkage

Published:2013-11 Issue:8 Volume:40 Page:1006-1012
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Yim Cheng-Bin,Mikkola Kirsi,Fagerholm Veronica,Elomaa Viki-Veikko,Ishizu Tamiko,Rajander Johan,Schlesinger Joern,Roivainen Anne,Nuutila Pirjo,Solin Olof

Funder

Academy of Finland

University of Turku

Turku University Hospital

Åbo Akademi University

European Community's Seventh Framework Programme (FP7/2007-2013)

Diabetes Research Foundation, Finland

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference47 articles.

1. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes;Naucka;Regul Pept,2005

2. Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005;Holst;Diabetologia,2006

3. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting;Wild;J Nucl Med,2006

4. Glucagon-like peptide 1-receptor scans to localize occult insulinomas;Wild;N Engl J Med,2008

5. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT;Wild;J Nucl Med,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ways to reduce radioactivity accumulation in the kidney during targeted therapy using small molecules, peptides and antibody fragments;Siberian journal of oncology;2024-09-09

2. New tactics in the design of theranostic radiotracers;npj Imaging;2024-08-02

3. Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands;Pharmaceuticals;2024-02-16

4. Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy;Pharmaceutics;2023-04-30

5. Enzymological Characterization of ⁶⁴Cu-Labeled Neprilysin Substrates and Their Application for Modulating the Renal Clearance of Targeted Radiopharmaceuticals;Journal of Medicinal Chemistry;2023-01-03